Vivo Opportunity Fund Holdings, 10% Owner: Bolt Biotherapeutics BOLT Sell · Filed 23/11/22

Trade details

Type: Insider sale
Amount: $1,536.3
Shares · price: 1,707 sh · $0.90 a share
Held after: 1,952,302 sh
Stock: Bolt Biotherapeutics BOLT
Person: Vivo Opportunity Fund Holdings10% Owner
Trade date: 23/11/21
Filed: 23/11/22
Days to filing: 1 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Bolt Biotherapeutics trades, last 26 weeks

What else happened in Bolt Biotherapeutics around then

Filed or reported within 30 days of the trade day · 23/10/22~23/12/21

Vivo Opportunity Fund Holdings's recent trades

Vivo Opportunity Fund HoldingsDirector
Planned saleUnicycive Therapeutics
Planned sale
Unicycive Therapeutics
UNCY
$9.5M
1,789,916 sh
$9.5M
Filed 07/01
Traded 06/30
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$79.6K
51,056 sh
$79.6K
Filed 06/10
Traded 05/20
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$78.4K
49,966 sh
$78.4K
Filed 06/10
Traded 06/05
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$52.2K
30,882 sh
$52.2K
Filed 06/10
Traded 05/21
Vivo Opportunity Fund Holdings10% Owner
BuyInMed Pharmaceuticals
Buy
InMed Pharmaceuticals
INM
$44.9K
29,518 sh
$44.9K
Filed 06/10
Traded 06/08